Cognitive Impairment in Multiple Sclerosis.

Bioengineering (Basel) · 2023 · PMC10376413 · PMID 37508898

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

For the pursuance of new strategies that can address cognitive loss in MS, APOE and infection with SARS-CoV-2 may be significant risk factors for MS.

also in 7,049 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.